In Brief: Perclose
This article was originally published in The Gray Sheet
Executive Summary
Perclose: Completes human testing of its two-suture Prostar Plus 8F percutaneous vascular surgical system, a second-generation device for vascular closure of the arterial access sites created by catheterization procedures. Clinically evaluated in Canada and France, Prostar Plus incorporates technology from Perclose's Techstar one-suture device into a two-suture system. Perclose, which says it is "very pleased by the initial clinical experience with the Prostar Plus 8F," plans to launch the product this quarter in Europe, Japan and Canada, noting that a 10F product is under development...